← Back to news

Markets

Tesla Robotaxi Service Expands To Dallas And Houston

Y

Petrobras Expands Africa Push With São Tomé Block 3 Deal

Y

Xanadu (XNDU) Soars 237% This Week. Nvidia May Hold The Answer

Y

Maase (MAAS) Soars 84% as Firm Expands AI Foothold

Y

Avis Budget (CAR) Soars 65% — Here’s Why

Y

Revolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial Results

Y

NextNav (NN) Up 49% as Firm Seen an Acquisition Target

Y

Hims & Hers (HIMS) Jumps 48% Ahead of Earnings

Y

Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential

Y

National Australia Bank flags $503 million impairment hit on Mideast volatility

Y

Travere Therapeutics (TVTX) Climbs 40.8% on Filspari Approval

Y

Mizuho Cuts PT on ADMA Biologics Inc. (ADMA) to $24 From $30

Y

Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29

Y

JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating

Y

Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating

Y

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Y

Why Mesoblast Limited (MESO) is One of the Best Low Priced Biotech Stocks to Invest in

Y

Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?

Y

Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI

Y

Guggenheim Cuts PT on Valneva SE (VALN) to $11 From $13

Y

B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14

Y

Cantor Fitzgerald Downgrades ADMA Biologics Inc. (ADMA) to Neutral From Overweight

Y

Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now?

Y

RBC Capital Lifts PT on Incyte Corporation (INCY) to $95 From $92

Y

Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now

Y

Raymond James Resumes Coverage of Jazz Pharmaceuticals (JAZZ) With an Outperform Rating

Y

Regeneron Pharmaceuticals (REGN) Announces Collaboration With Telix Pharmaceuticals Limited

Y

AMD: $600 Bullseye

S

Shiba Inu vs. Dogecoin: Which Meme Coin Is the Less Risky Bet?

Y

Stock market today: S&P 500, Nasdaq, Dow futures fall as hopes of de-escalation in Iran dwindle

Y

Stock market today: S&P 500, Nasdaq, Dow futures fall as US-Iran tensions flare up again to shutter Hormuz

Y

Stock market today: S&P 500, Nasdaq, Dow fall as US-Iran tensions flare up again, shuttering Hormuz

Y

Stock market today: S&P 500, Nasdaq, Dow edge lower as US-Iran tensions flare up again, shuttering Hormuz

Y

Most Americans Can't Afford a Funeral — 58% Say They'd Go Into Debt Over The $8,300 Cost

Y

Why I withdrew everything from Aave this weekend

Y

Middle East Oil Pricing Is Cracking Under Pressure

Y

Looking For a Way to Profit from the SpaceX IPO? This Top AI Stock Owns a $100 Billion Stake in the Elon Musk-led Rocket and Satellite Leader.

Y

Peter Schiff Warns Zohran Mamdani's Government Grocery Plan Will Be 'Far Less Efficient' — Mayor Says 'I Look Forward To The Competition'

Y

Wall Street Turbulence: How Resilient is Nvidia?

Y

Binance Is Suing a Newspaper in the One Place It Probably Shouldn’t

Y

Suze Orman: This Overlooked Health Insurance Detail Could Cost You Thousands in 2026

Y

If Netflix Can Keep Winning on This Key Metric, the Stock Could Soar

Y

Latest acquisition by Brad Jacobs’ QXO building products rollup is largest so far

Y

1 No-Brainer Growth Stock to Buy With $30 Right Now

Y

Silver Is Outperforming Gold in 2026. Does SLV Deserve a Spot in Your Portfolio?

Y

Downsizing? Here's how to make sure you don't get dinged with a Medicare premium surcharge

Y

Cramer Highlights Nike, Amazon, Nvidia Stock To Investors: 'Why Would You Sell It?'

Y

AI Absorbs $242 Billion in Q1 Venture Funding, Exceeding All of 2025 Combined

Y

AI startup Cursor in talks to raise $2 billion funding round at valuation of over $50 billion

F

Prediction: It's Not Too Late to Buy Broadcom Stock After Another Win for the Company

Y